Open AccessDrug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculous drugs: A five years study
Author(s) -
Sarala Me,
Sujata Dharmshale,
Chhaya Chande,
Aruna Gohil,
Sunil Lilani,
Salim Mohammad,
Ameeta Joshi,
Abhay Chowdhary,
Renu Bharadwaj
Publication year - 2012
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.99104
Subject(s) - ethambutol , rifampicin , isoniazid , medicine , streptomycin , drug resistance , mycobacterium tuberculosis , tuberculosis , drug , antibiotics , microbiology and biotechnology , virology , pharmacology , biology , pathology
Drug resistance is a major problem in the treatment of tuberculosis (TB). An estimate of drug resistance is extremely important in the epidemiology and control of TB. However, an assessment of the magnitude of drug resistance in TB is not very well described globally and data remains scantier for India. In view of this, we reviewed our data over last five years.